Literature DB >> 1246464

Hereditary sever combined immunodeficiency and adenosine deaminase deficiency.

C Ackeret, H J Llüss, W H Hitzig.   

Abstract

A retrospective study aiming at detection of heterozygous carriers of blood adenosine deaminase (ADA) deficiency was carried out in nine families known to us because children had died of combined immunodeficiency (SCID). The trait was found in 3 of 9 parent couples, and in 14 other relatives. In two families one homozygous patient was identified. A total of 54 family members and 60 healthy control subjects were tested. Clinically, the patients were all characterized by marked lymphopenia, nearly normal immunoglobulin levels, and inability to produce antibodies. One homozygous patient recovered after transplantation of fetal liver and thymus and is immunologically normal 1.5 years afterwards.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246464     DOI: 10.1203/00006450-197601000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease.

Authors:  B Löwenberg; J M Vossen; L J Dooren
Journal:  Blut       Date:  1977-03

Review 2.  Combined immunodeficiency and inborn errors of purine metabolism.

Authors:  H J Meuwissen; B Pollara
Journal:  Blut       Date:  1978-10-13

Review 3.  The biochemical basis of immunodeficiency disease.

Authors:  K O Raivio
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

Review 4.  Conception and development of the fetal tissue bank.

Authors:  S D Lawler
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

5.  [Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)].

Authors:  B H Belohradsky; N Hennig; W Marget; H H Fudenberg
Journal:  Klin Wochenschr       Date:  1976-12-01

6.  Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.

Authors:  H Ratech; R Hirschhorn; M A Greco
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

7.  Expression of human adenosine deaminase using a transmissable murine retrovirus vector system.

Authors:  R L Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency.

Authors:  R Pahwa; S Pahwa; R A Good; G S Incefy; R J O'Reilly
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  A new approach to detection of heterozygotes for adenosine deaminase deficiency: a hypothetical method.

Authors:  N Sakura; T Usui; K Ito; K S Ha; T Ikeda; H Yabuuchi; N Iwanami; A Komiyama; T Akabane
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.